Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-22-000007

Options or other derivatives

  • Chief Business Officer acquired 325,850 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

McElhaugh Michael J. · Chief Business Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +325,850 $2.81 $915,639 325,850 D
Loading xslF345X03/wf-form4_164271921610822.xml…